feed,title,long_url,short_url
Benzinga,"Can-fite biopharma gains analyst ""buy"" distinction and signs new distribution agreements for its lead drug candidates",https://benzinga.com/general/biotech/21/05/21082603/can-fite-biopharma-gains-analyst-buy-distinction-and-signs-new-distribution-agreements-for-its-le,https://j.mp/3odUdrw
Benzinga,"Tower Semiconductor Beats On Q1 Revenue, Q2 Revenue Guidance Marginally Above Consensus",https://benzinga.com/news/earnings/21/05/21080133/tower-semiconductor-beats-on-q1-revenue-q2-revenue-guidance-marginally-above-consensus,https://j.mp/3f89s0S
